3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Thalassemia
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Immunologic Deficiency Syndromes
1
Hemoglobinopathies
1
Hematologic Neoplasms
1
Fanconi Anemia
1
Anemia, Sickle Cell
1
Interventions
fludarabine
3
Melphalan
2
fludarabine phosphate
1
Thiotepa
1
Mesna
1
Influenza Vaccines
1
Honey
1
Cyclophosphamide
1
Clofarabine
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Immunologic Deficiency Syndromes
×
fludarabine phosphate
×
Clear all
NCT01316549
2021-10-04
HCT
University of California, San Francisco
Completed
67 enrolled